Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have Type 2 Diabetes (T2D)
Have an HbA1c value at screening of ≥7.0% and ≤10.5% and treated with diet and exercise alone or with a stable dose of metformin (either immediate release or extended release, 1000 milligram (mg)/day and not more than the locally approved dose) for at least 3 months prior to screening.
You may not be if
Have type 1 diabetes mellitus (T1DM)
Have ketoacidosis
Have retinopathy, maculopathy
Have history of pancreatitis
Have obesity induced by other endocrine disorders
Have uncontrolled hypertension
Have acute or chronic hepatitis
Have chronic kidney disease
Have an autoimmune abnormality for example, lupus or rheumatoid arthritis
Have an active or untreated malignancy
Clareo Health | A Study of LY3437943 in Participants With Type 2 Diabetes
